Researchers develop a single genome-editing strategy to treat multiple disorders caused by nonsense mutations, promising efficient and cost-effective therapies.
Commercially-insured patients can pay as little as $0 on their copay and up to $2,000 per fill for their PANCREAZE® prescriptionCAMPBELL, ...
Types 1 and 2 diabetes can significantly increase your risk of exocrine pancreatic insufficiency (EPI). Here’s what you need to know to reduce your risk.
Those of us who watch the Olympics as bystanders tend to smugly judge athletes for succumbing to pressure without ...
The ALPHA-PE Research Fund Supports Independent, Physician-Led Studies to Advance Real-World PE Evidence AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company ...
Cancer drugs among nearly 400 medicines at risk of shortage in UK - Exclusive: Drugs to treat stroke and schizophrenia ...